FDA Sets Flu Shot Recommendations
- on Thursday, the Food and Drug Administration (FDA) announced its recommendations to influenza vaccine manufacturers regarding the specific virus strains to be included in the upcoming flu vaccines.
- The FDA is recommending that flu vaccines for the 2025-26 season be trivalent, protecting against two strains of influenza A and one of influenza B.
- The FDA anticipates that there will be an "adequate and diverse supply of approved trivalent seasonal influenza vaccines for the 2025-2026 U.S.
FDA Issues Flu Vaccine Recommendations for 2025-2026 Season
Table of Contents
- FDA Issues Flu Vaccine Recommendations for 2025-2026 Season
- FDA Issues 2025-2026 Flu Vaccine Recommendations: Your Questions Answered
Published:
FDA Recommends Strains for 2025-2026 Flu Vaccine
on Thursday, the Food and Drug Administration (FDA) announced its recommendations to influenza vaccine manufacturers regarding the specific virus strains to be included in the upcoming flu vaccines. These vaccines are intended for the 2025-2026 influenza season.
The FDA is recommending that flu vaccines for the 2025-26 season be trivalent, protecting against two strains of influenza A and one of influenza B.
The FDA anticipates that there will be an “adequate and diverse supply of approved trivalent seasonal influenza vaccines for the 2025-2026 U.S. influenza season.”
Canceled Advisory Meeting Raises Concerns
typically, the FDA formulates its advice after consulting with a committee of external advisors. A meeting was scheduled for March 13 to discuss the influenza vaccine strains for the 2025-2026 influenza season. Though, this meeting was abruptly canceled, raising concerns among some experts.
The cancellation of the advisory meeting followed the postponement of another vaccine panel meeting involving advisors to the Centers for Disease Control and Prevention (CDC). This sequence of events has prompted some public health experts to express concern that Robert F. Kennedy Jr., in his role as health secretary, may seek to alter or disrupt existing processes for vetting vaccines.
Decision-Making Process
The FDA made its strain suggestion after agency officials met with staff from the CDC and the Department of Defence. similar to the previous year,they advised vaccine makers to prepare trivalent shots targeting the H1N1,H3N1,and B/Victoria influenza lineages. This decision was reached after reviewing data on currently circulating strains and the efficacy of available vaccines.
Lawmaker Concerns and Clarity
While the recommendations of the FDA’s outside advisors usually align with international guidelines, lawmakers have voiced concerns that canceling the meeting reduced transparency in the process. Senators on the health committee questioned Marty Makary, President Donald Trump’s nominee to run the FDA, about the issue. He denied any involvement in the decision to cancel,but stated he would reevaluate which topics “deserve a convening of the advisory committee members” and which may not.
The committee voted 14-9 to advance Makary’s nomination to the full Senate. if confirmed, Makary would report to Kennedy, who has a history of questioning the safety and efficacy of established vaccines.
Ongoing Debates on Vaccine Safety
Kennedy has claimed a link between vaccination and rising autism diagnoses, despite numerous studies finding no such association.The CDC is reportedly planning to study the issue,which is a top concern among the White House’s Make America Healthy Again Commission.
Amidst these discussions, there is a growing outbreak of measles in Texas, where the first death from the disease as 2015 was recently reported.While Kennedy has recommended people discuss vaccination with their doctor, he has also promoted fringe theories and reiterated his view that vaccination is a “personal choice.”
FDA Issues 2025-2026 Flu Vaccine Recommendations: Your Questions Answered
Published:
Understanding the 2025-2026 Flu Vaccine Recommendations
What strains will the 2025-2026 flu vaccine protect against?
The FDA is recommending that the 2025-2026 flu vaccines be trivalent. This means thay will protect against three influenza virus strains: two strains of influenza A and one strain of influenza B. The specific lineages targeted are H1N1,H3N1 and B/Victoria influenza.
What does ”trivalent” mean in the context of flu vaccines?
A “trivalent” flu vaccine means that the vaccine is designed to protect against three different influenza viruses. in the case of the 2025-2026 vaccine, it will include two influenza A strains and one influenza B strain. This is different from quadrivalent vaccines, which protect against four strains (two influenza A and two influenza B strains).
Will there be enough flu vaccine available for the 2025-2026 flu season?
The FDA anticipates an adequate and diverse supply of approved trivalent seasonal influenza vaccines for the 2025-2026 U.S. influenza season. However, availability can vary by location and time of year, so itS always best to check with your healthcare provider or local pharmacies early in the season.
Who should get the flu vaccine?
While the specific recommendations for the 2025-2026 season are still developing, generally, the CDC recommends that everyone 6 months and older receive an annual flu vaccine. Certain groups are at higher risk of serious complications from the flu, including:
- young children
- Older adults
- pregnant women
- People with certain chronic health conditions like asthma, diabetes, and heart disease
Consult with your healthcare provider to determine if the flu vaccine is appropriate for you.
when is the best time to get the flu vaccine?
While it’s best to get vaccinated before flu season begins, typically in the fall (September or October), it’s still beneficial to get vaccinated even later in the season. Flu season can start as early as October and last as late as May.
Concerns Regarding the Vaccine Advisory Process
Why was the FDA advisory meeting canceled,and what are the concerns surrounding it?
The FDA canceled a pivotal advisory meeting scheduled for March 13 to discuss influenza vaccine strains for the 2025-2026 season. This cancellation, along with the postponement of a CDC vaccine panel meeting, has raised concerns among some public health experts. Some worry that these cancellations might indicate an attempt to alter or disrupt established processes for vetting vaccines, potentially influenced by figures questioning vaccine safety.
How does the FDA usually decide on flu vaccine strains?
Typically, the FDA formulates its advice after consulting with a committee of external advisors. These advisors review data on currently circulating strains and the effectiveness of available vaccines to help the FDA make informed recommendations.
What is the potential impact of canceling advisory meetings?
Lawmakers have voiced concerns that canceling the advisory meeting reduced clarity in the decision-making process. Input from outside experts usually aligns with international guidelines, and their absence raises questions about the robustness of the FDA’s decision.
Decision-Making and Political Influences
How did the FDA make its decision on the 2025-2026 flu vaccine strains?
The FDA made its strain suggestion after agency officials met with staff from the CDC and the Department of Defense. They reviewed data on currently circulating strains and the efficacy of available vaccines to align with previous years, and advised vaccine makers to prepare trivalent shots targeting the H1N1, H3N1, and B/Victoria influenza lineages.
Who is Marty Makary, and what is his role in the FDA?
Marty Makary is President Donald Trump’s nominee to run the FDA. Senators on the health committee questioned him about the canceled advisory meeting.While he denied involvement in the decision, he stated he would reevaluate which topics deserve a convening of the advisory committee members and which may not. The committee voted to advance his nomination to the full Senate.
What are the concerns surrounding Robert F. Kennedy Jr.’s potential influence?
If confirmed,Makary would report to Robert F. Kennedy Jr., who has a history of questioning the safety and efficacy of established vaccines. This raises concerns among some public health experts, as Kennedy has promoted fringe theories about vaccines and their link to conditions like autism, despite scientific evidence to the contrary.
Vaccine Safety and Public Health
What is the current stance on the link between vaccines and autism?
Numerous studies have found no association between vaccination and autism diagnoses. This claim has been repeatedly debunked by the scientific community. The CDC is reportedly planning to study the issue further, as it remains a top concern among the White House’s Make America Healthy Again Commission.
What is the current status of measles outbreaks in the U.S.?
There is a growing outbreak of measles in Texas, where the first death from the disease since 2015 was recently reported. This highlights the importance of vaccination in preventing the spread of infectious diseases.
what are the key takeaways regarding flu vaccine recommendations?
The FDA has issued its recommendations for the 2025-2026 flu season. The vaccine is expected to be trivalent, protecting against two influenza A strains and one influenza B. while an advisory meeting was canceled, raising some concerns, the FDA, CDC, and Department of Defense collaborated to make the recommendations.It’s crucial to stay informed, discuss your concerns with a healthcare provider, and prioritize vaccination to protect yourself and the community.
Summary of Key Data
Hear’s a table summarizing the key information about the 2025-2026 flu vaccine:
| Topic | Details |
|---|---|
| Vaccine Type | Trivalent (2 influenza A strains, 1 influenza B strain) |
| Targeted Strains | H1N1, H3N1, B/Victoria lineages |
| Advisory Meeting | Canceled, raising concerns about transparency |
| Decision-Making Process | FDA met with CDC and Department of Defense staff |
| Availability | Adequate and diverse supply expected |